CT3204 pMDI Leak Detection System Datasheet

The CT3204 pMDI Leak Detection and Reject System, primarily used for pharmaceutical applications, provides customers with a step change in capability over existing test methods. Manufacturers of metered dose inhalers are required by the FDA to test every single unit for leakage. The way this is currently handled is to weigh the products, then “quarantine” each unit for between two and four weeks, and then reweigh to determine if there has been any leakage. This is a costly, time consuming, inefficient process.